1. Loss of TACI Causes Fatal Lymphoproliferation and Autoimmunity, Establishing TACI as an Inhibitory BLyS Receptor
- Author
-
Iqbal S. Grewal, Vishva M. Dixit, Patricia Valdez, Minhong Yan, Daniel Tumas, and Dhaya Seshasayee
- Subjects
Glomerulonephritis, Membranoproliferative ,Recombinant Fusion Proteins ,Transmembrane Activator and CAML Interactor Protein ,medicine.medical_treatment ,Immunology ,Apoptosis ,Biology ,Receptors, Tumor Necrosis Factor ,Autoimmune Diseases ,Mice ,B cell homeostasis ,medicine ,Animals ,Humans ,Lupus Erythematosus, Systemic ,Immunology and Allergy ,BAFF receptor ,B-cell activating factor ,Receptor ,B cell ,Mice, Knockout ,B-Lymphocytes ,Transmembrane activator and CAML interactor ,B-Cell Maturation Antigen ,Membrane Proteins ,Cell Differentiation ,Lymphoproliferative Disorders ,Protein Structure, Tertiary ,Phenotype ,Infectious Diseases ,medicine.anatomical_structure ,Cytokine ,B-Cell Activation Factor Receptor - Abstract
BLyS, a key cytokine that sustains B cell maturation and tolerance, binds three receptors: BR3, BCMA, and TACI. Results from knockout mice implicate a major functional role for BR3 and a redundant one for BCMA in B cell function. TACI's role is controversial based on defects in TI antibody responses accompanied by B cell hyperplasia in knockout mice. We have presently characterized a precise role for TACI in vivo. TACI −/− mice develop fatal autoimmune glomerulonephritis, proteinurea, and elevated levels of circulating autoantibodies. Treatment of B cells with TACI agonistic antibodies inhibits proliferation in vitro and activation of a chimeric receptor containing the TACI intracellular domain induces apoptosis. These results demonstrate the critical requirement for TACI in regulating B cell homeostasis.
- Published
- 2003